Lipid-based nanoparticulate delivery systems for HER2-positive breast cancer immunotherapy
Nima Behravan, Fatemeh Zahedipour, Mahmoud Reza Jaafari, Thomas P. Johnston, Amirhossein Sahebkar
Topics & Concepts
Breast cancerImmunotherapyMedicineCancerBiomarkerTrastuzumabDrug deliveryCancer researchCancer immunotherapyClinical trialPharmacologyOncologyInternal medicineBiologyNanotechnologyMaterials scienceBiochemistryMonoclonal and Polyclonal Antibodies ResearchNanoparticle-Based Drug DeliveryImmunotherapy and Immune Responses